Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human papillomavirus vaccines: a warty problem

D A Galloway1

  • 1Fred Hutchinson Cancer Research Center, Seattle, WA 98040.

Infectious Agents and Disease
|August 1, 1994
PubMed
Summary

Developing vaccines against human papillomaviruses (HPVs) is feasible. Research focuses on prophylactic and therapeutic vaccines to combat HPV infections, genital warts, and cervical cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

E2F1-3 activate Merkel cell polyomavirus early transcription and replication.

bioRxiv : the preprint server for biology·2025
Same author

Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia.

Oral diseases·2014
Same author

Regulation of telomerase by human papillomaviruses.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis.

Tissue antigens·2005
Same author

HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women.

Rheumatology (Oxford, England)·2004
Same author

Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk.

Cancer research·2001

Area of Science:

  • Virology
  • Immunology
  • Oncology

Background:

  • Human papillomaviruses (HPVs) are common causes of genital warts, dysplasia, and invasive cancers.
  • Current diagnostic and treatment approaches for HPV infections are costly and not fully effective.
  • HPV infection is highly prevalent, and cervical cancer remains a leading cancer in women globally.

Purpose of the Study:

  • To explore the feasibility of developing prophylactic and therapeutic vaccines against HPV.
  • To identify potential vaccine targets, including L1/L2 capsid proteins and E6/E7 oncoproteins.

Main Methods:

  • Review of HPV genome structure and genetic stability.
  • Analysis of existing research on vaccines against animal papillomaviruses.
  • Consideration of challenges in HPV vaccine efficacy studies.

Main Results:

  • The relative simplicity of the HPV genome and lack of genetic variability support vaccine development.
  • Encouraging results from vaccines against animal papillomaviruses suggest potential for human vaccines.
  • Challenges include the inability to culture the virus and incomplete understanding of HPV natural history.

Conclusions:

  • Prophylactic and therapeutic HPV vaccines are potentially feasible.
  • Further research is needed to overcome challenges in vaccine efficacy demonstration and to fully understand HPV infection.
  • Vaccine development holds promise for preventing HPV-related diseases, including cervical cancer.

Related Experiment Videos